Biotechnology · Healthcare
CFO, CEO
2025-06-11–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Canton Strategic Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNTN alertsSireesh Appajosyula is recorded as CFO at Canton Strategic Holdings, Inc. (CNTN) since November 7, 2025 and CEO at Canton Strategic Holdings, Inc. (CNTN) since June 11, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed November 10, 2025 that Sireesh Appajosyula was appointed interim Chief Financial Officer, effective November 7, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed June 11, 2025 that Sireesh Appajosyula was appointed Chief Executive Officer, effective June 11, 2025. Canton Strategic Holdings, Inc. reported in an 8-K filed July 11, 2023 that Sireesh Appajosyula was appointed Chief Operating Officer, effective July 11, 2023. Equibles holds 5 filed executive changes naming Sireesh Appajosyula; each is listed under recent activity with its source filing. The proxy statement of Canton Strategic Holdings, Inc. reports total compensation of $2,881,544 for Sireesh Appajosyula in fiscal 2025, including a base salary of $376,255. Disclosed compensation is on record for 4 fiscal years. Canton Strategic Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Canton Strategic Holdings, Inc. includes Mark Wendland (CEO, Chairman and Board Member), Vincent LoPriore (Chairman), Don Kim (CFO) and 7 others.
“On November 7, 2025, the Board of Directors of Tharimmune, Inc. (the "Company") appointed Sireesh Appajosyula as interim Chief Financial Officer for a period not to extend beyond December 31, 2025.”
“On June 11, 2025, the Board appointed Sireesh Appajosyula as the Company's Chief Executive Officer, effective immediately.”
2025-11-07–present
2025-06-11–present
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
CFO, CEO
2025-06-11–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Canton Strategic Holdings, Inc. (CNTN) | Former Interim Chief Financial Officer, Chief Operating Officer and Chief Executive Officer | $376,255 | $2,881,544 |
| 2024 | Canton Strategic Holdings, Inc. (CNTN) | Previous Interim Chief Financial Officer | $407,108 | $700,625 |
| 2023 | Canton Strategic Holdings, Inc. (CNTN) | Previous Interim Chief Financial Officer | $184,615 | $387,685 |
| 2022 | Canton Strategic Holdings, Inc. (CNTN) | Chief Operating Officer | — | — |